The FDA-approved OmniaSecure defibrillation lead from Medtronic is a thin wire that connects an implantable cardioverter defibrillator to the heart.
CMS has approved electrophysiology ablation procedures for the ASC setting, marking a major advancement for outpatient cardiology and potentially accelerating the specialization of cardiac ASCs.
For high-risk patients, the method could offer a safer alternative to open-heart surgery.
"Marshall’s rich experience strengthens our board as we move into our next phase of growth," CEO Maggie Nixon said.
"Publication of the new AMA CPT code represents a significant milestone for Sensydia, and will help foster the adoption of our nninvasive, in-clinic hemodynamic assessment tool by establishing a ...
LARGO, Fla. — Marsha Grever was a ticking time bomb. Dr. Saurabh Sanon knew she would have died if she didn't get help for her heart. Grever, 75, had already had three open heart surgeries. A fourth ...
Capstan Medical, a developer of robotic-enabled, minimally invasive solutions to address heart valve disease, today announced the appointment of Marshall Mohr to its Board of Directors to further ...